The PennZone

  • Home
  • Non-profit
  • Business
  • Education
  • Construction
  • Health
  • Technology
  • Entertainment
  • Software

Beneficience.com Legacy PR Announces Dr. Burd Renowned Diabetes Scientist, Biochemist-entrepreneur and Dexcom Founder, client
The PennZone/10216335

Trending...
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • Philadelphia's First Ginger Store Honored With City Citation for Nine Years of Health and Wellness
  • RAATV Premieres Original Reality Series "The Access Index: Jackson" June, 19
Beneficience Com Announces Dr John Burd, Renowned Dr John Burd Lysulin© Dr Burd Wonder Spray Skin Rescue 8oz Skin Rescue Lysulin© Products Beneficience.com Legacy PR
Dr. Burd is a renowned diabetes scientist and biochemist and Founder of Dexcom, the worldwide leader in Continuous Glucose Monitoring (CGM) systems. Get to know him and what good he is doing in the world, and for whom his life work benefits.

SAN DIEGO - PennZone -- About John Burd, PhD:

Dr. Burd is Founder & CEO of Lysulin, Inc and Wonder Spray, llc.  In 2017 Dr. Burd founded Lysulin, Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes.   The first patented product, Lysulin®, was launched in January 2018 and is showing remarkable results in clinical studies in lowering HbA1c and glycated proteins, the cause of disease complications.  In 2019 Dr. Burd founded Wonder Spray, llc to provide relief for a variety of ailments and skincare problems using a natural and safe chemical that is used by white blood cells to kill all pathogens.

Dr. Burd was previously President & CEO of DexCom, where he directed the company's work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes.  In April 2005, DexCom completed a successful IPO, valuing the company at over $500 million.  In 2020 DexCom had a market cap of over $40 billion.  From 1999 to 2004 Dr. Burd was a General Partner of Windamere Venture Partners.

Before founding DexCom, Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, which developed and marketed the Duetâ Diabetes Control System to healthcare professionals and the In ChargeÔ Diabetes Control System to the diabetes self-testing market.  LXN was sold to Johnson and Johnson in 2000.

More on The PennZone
  • Ashley Wineland's 'Love + Heartbreak' Tour Brings her Emotional and Empowering Album 'Wineland' to Nationwide Audiences
  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • With a Dream and a Team, Monalisa Okojie Is Empowering the Next Generation Through EXPOSE NGO
  • Best Companies Group Launches Best Places to Work in PA Program
  • American Properties Realty, Inc. Celebrates 2026 FAME Awards - Community of the Year - Heritage at South Brunswick

Previously, Dr. Burd held executive positions at QUIDEL Corporation, where he directed the development of enzyme immunoassay products for the clinical lab, physician's office and OTC markets. Prior to joining QUIDEL, Dr. Burd was Executive Vice President and COO for MAST Immunosystems, Inc. where he was responsible for the company's operations, including research and development, marketing, sales and finance.  MAST Immunosystems was purchased by Hitachi Chemical in 1997.  Previously, Dr. Burd was involved in other medical product research and development at Miles Laboratories, Inc. (now Bayer Corporation).

Dr. Burd has authored and co-authored over 45 articles and his work in the medical and biotechnology field has led to the filing and ownership of forty patents and the development of many innovative medical products.  He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.  In 2010 Dr. Burd was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.

Disclaimer: Dr. Burd's published product statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

JOHN F. BURD, Ph.D.

Founder & CEO Lysulin, Inc and Wonder Spray, llc.

More on The PennZone
  • Mel Blackwell to Keynote 2026 NSSF Marketing and Leadership Summit
  • SmartCone and Samsung Launch RoadDefender™ to Enhance Real-Time Safety for Roadside Workers
  • The Personal Development Industry Has a Blind Spot Says Global Personal Success Guru Omar L. Harris
  • Kevin "Mr. Wonderful" O'Leary Begins New Universal Coin & Bullion Promotion of Gold and Silver
  • Flamingo Compliance Launches Schengen Area Trip Planning Tools as New Digital Border Controls Take Effect

4930 Bradshaw Court, San Diego, CA  92130
Phone: 619-992-2873

Website: Promotes Healthy Insulin Function and helps maintain healthy A1c (lysulin.com)

Learn more about Dr. Burd's products below...

Insulin resistance: https://www.youtube.com/watch?v=rdiHqff3EY8



Lysulin video:  https://www.youtube.com/watch?v=PK3CkMty6RE



Running A1c test: https://tinyurl.com/y379jbla

Wonder Spray:
https://www.youtube.com/channel/UCYFv1jgn3LmADcZklzLbMHA/videos

Follow Burd's PR News at http://Beneficience.com

MEDIA REQUESTS + MEDIA BOOKING: Dr. Burd is available for relevant events, speaking engagements, radio, podcast, television and media opportunities, news interviews, et als. Burd's media contact information is available now by request online at Beneficience.com Legacy PR at https://beneficience.com/?s=Dr.+John+Burd

Contact
Dr. Tracey Bond, MPRL
Certified Publicist of Record
for John Burd, PhD
***@beneficience.com


Source: Beneficience.com Legacy PR
Filed Under: Business, Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • VeneerVibe Releases 2026 Snap-On Veneers Market Report
  • David Cavanagh Launches AI SEO Company For ChatGPT And AI Search Visibility
  • Matthew Cossolotto Spotlights Make a Promise Day 2026 Events, Including Official Launch of Harness Your PromisePower and Issuing a "Peace Promise"
  • Landmark Expands Services to Include Specialized Glass and Glazing Solutions Across Los Angeles
  • As Pentagon Releases Ufo Files, Debut Ya Novel Predicted It All
  • RAATV Premieres Original Reality Series "The Access Index: Jackson" June, 19
  • Connecticut Resident Develops Patent-Pending Concept Exploring a New Approach to GPS Navigation
  • JP Events Azerbaijan to Host 2nd Women in Motorsport Event During the Azerbaijan Grand Prix Week
  • MMA Platform Makes History, Pays Jamey-Lyn Horth After Fans Vote on UFC Winnipeg Robbery
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • Premiere Venue Group Announces $25,000 Sponsorship to Support Ann's Heart Programs and Events
  • L2 Aviation Awarded IDIQ Contract by the U.S. Army for M1A2 Abrams Tank
  • Sycor.Rental Named Among 2026 Best Microsoft Dynamics ERP Supply Chain Solutions
  • KDG Redefines Enterprise Software Development with AI-Assisted and Agentic Delivery Model
  • Beyond Medication: Kellyn Foundation And Highmark Wholecare Tackle Type 2 Diabetes, Obesity With Comprehensive Lifestyle Program
  • TrueNorth Wellness Services Raises $10,066 During Give Local York 2026
  • Smart Tools App Brings 100+ Everyday Utilities Into One Android Solution
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • Philadelphia's First Ginger Store Honored With City Citation for Nine Years of Health and Wellness
  • ICTPBX Released: White-Label, Multi-Tenant Open Source PBX Platform for ITSPs

Popular on PennZone

  • The Finger Comb, a Dream Inspired 3-in-1 Styling Tool introduced by Andrea L. Randolph - 129
  • Dog Grooming Businesses Turn to Performance-Based Platforms to Attract Local Clients
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • New plusOne Research Finds the Orgasm Gap Is a 30-Point Chasm — and Confirms It Isn't Biology
  • A Powerful Beginning Inside One of Philadelphia's Most Inspiring Early Childhood Education Centers
  • AWARENESS TO WELLNESS: Imhotep Institute Charter High School
  • Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
  • Strategic Talent Associates Launches THE ALIGNED RESET™
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella

Similar on PennZone

  • Client 1st Financial and Keystone Financial Management Donate 550+ Pounds of Food to New Bethany Inc
  • Mensa Foundation Event Reframes Brain Health for Every Age
  • DLT Resolution, Inc. (Stock Symbol: DLTI) Expands Into the $224 Billion Life Settlements Market While Accelerating Telecom Growth Across Canada
  • Ashley Wineland's 'Love + Heartbreak' Tour Brings her Emotional and Empowering Album 'Wineland' to Nationwide Audiences
  • With a Dream and a Team, Monalisa Okojie Is Empowering the Next Generation Through EXPOSE NGO
  • The Personal Development Industry Has a Blind Spot Says Global Personal Success Guru Omar L. Harris
  • HHS Announces Major Push to Address Psychiatric Drug Risks: CCHR Applauds Focus on Informed Consent and Safe Tapering
  • @tickerbitcoinbb and @girl_still_cute Announce the Arrival of SPROTO AEON BABY 1.0 – A New Chapter for the HarryPotterObamaSonic10Inu Universe
  • Michigan Fitness Foundation Gifts EPEC Moves K–5 PE Curriculum Program to Educators during Michigan Moves Month
  • Sidow Sobrino, the One and Only World's No.1 Superstar®, Launches Dangerous Joy
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us